pH-Responsive Hybrid Nanoassemblies for Cancer Treatment: Formulation Development, Optimization, and In Vitro Therapeutic Performance.
Pharmaceutics
; 15(2)2023 Jan 18.
Article
in En
| MEDLINE
| ID: mdl-36839648
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Pharmaceutics
Year:
2023
Document type:
Article
Affiliation country:
Portugal